Gastrectomia D2 nel trattamento chirurgico del cancro gastrico.

V. Ceriani; P. Bignami; E. Faleschini; T. Lodi; O. Roncaglia; C. Osio; D. Sarli

Gastrectomia D2 nel trattamento chirurgico del cancro gastrico.

Translated title of the contribution: D2 gastrectomy in the surgical treatment of gastric cancer

V. Ceriani, P. Bignami, E. Faleschini, T. Lodi, O. Roncaglia, C. Osio, D. Sarli

IRCCS Multimedica

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The study is conducted on a series of 57 patients treated with D2 gastrectomy with curative intent for gastric cancer between January 2000 and December 2004, at Policlinico Multimedica (Milan). Postoperative mortality was 2%. Recurrence rate was 10%. The overall survival of the series is 36% at 4 years follow-up. Negative prognostic factors were: high grade tumor, locally advanced primary disease, presence of lymph node metastases, advanced stage of disease and recurrent disease at follow-up. The data of the study are comparable to those in the literature.

Translated title of the contribution	D2 gastrectomy in the surgical treatment of gastric cancer
Original language	Italian
Title of host publication	I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]
Volume	4
Edition	3
Publication status	Published - 2005

Access to Document

Fingerprint Dive into the research topics of 'D2 gastrectomy in the surgical treatment of gastric cancer'. Together they form a unique fingerprint.

Cite this

@inbook{f87ec80201a444a8b6a2aecf5f7a1657,

title = "Gastrectomia D2 nel trattamento chirurgico del cancro gastrico.",

abstract = "The study is conducted on a series of 57 patients treated with D2 gastrectomy with curative intent for gastric cancer between January 2000 and December 2004, at Policlinico Multimedica (Milan). Postoperative mortality was 2%. Recurrence rate was 10%. The overall survival of the series is 36% at 4 years follow-up. Negative prognostic factors were: high grade tumor, locally advanced primary disease, presence of lymph node metastases, advanced stage of disease and recurrent disease at follow-up. The data of the study are comparable to those in the literature.",

author = "V. Ceriani and P. Bignami and E. Faleschini and T. Lodi and O. Roncaglia and C. Osio and D. Sarli",

year = "2005",

language = "Italian",

volume = "4",

booktitle = "I supplementi di Tumori : official journal of Societ{\`a} italiana di cancerologia ... [et al.]",

edition = "3",

}

TY - CHAP

T1 - Gastrectomia D2 nel trattamento chirurgico del cancro gastrico.

AU - Ceriani, V.

AU - Bignami, P.

AU - Faleschini, E.

AU - Lodi, T.

AU - Roncaglia, O.

AU - Osio, C.

AU - Sarli, D.

PY - 2005

Y1 - 2005

N2 - The study is conducted on a series of 57 patients treated with D2 gastrectomy with curative intent for gastric cancer between January 2000 and December 2004, at Policlinico Multimedica (Milan). Postoperative mortality was 2%. Recurrence rate was 10%. The overall survival of the series is 36% at 4 years follow-up. Negative prognostic factors were: high grade tumor, locally advanced primary disease, presence of lymph node metastases, advanced stage of disease and recurrent disease at follow-up. The data of the study are comparable to those in the literature.

AB - The study is conducted on a series of 57 patients treated with D2 gastrectomy with curative intent for gastric cancer between January 2000 and December 2004, at Policlinico Multimedica (Milan). Postoperative mortality was 2%. Recurrence rate was 10%. The overall survival of the series is 36% at 4 years follow-up. Negative prognostic factors were: high grade tumor, locally advanced primary disease, presence of lymph node metastases, advanced stage of disease and recurrent disease at follow-up. The data of the study are comparable to those in the literature.

UR - http://www.scopus.com/inward/record.url?scp=33644851839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644851839&partnerID=8YFLogxK

M3 - Capitolo

C2 - 16437925

AN - SCOPUS:33644851839

VL - 4

BT - I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]

ER -